Kitsap Provider Resources

Health Advisory: Paxlovid Granted EUA and Testing Before Gathering

Actions Requested Be aware, Food and Drug Administration (FDA) granted emergency use authorization (EUA) to the first oral antiviral treatment for COVID-19, Pfizer’s Paxlovid. The EUA comes after research showed Paxlovid was nearly 90% effective at preventing hospitalization and death in people 12 years or older at high risk of severe outcomes within 5 days Health Advisory: Paxlovid Granted EUA and Testing Before Gathering

Kitsap Respiratory Illness Report December 5 – December 11, 2021

Click here to access the latest Kitsap Respiratory Illness Report: 12.5.21 – 12.11.21.

Health Advisory: Opportunity to Participate in a Medication for Opioid Use Disorder (MOUD) Learning Collaborative

Actions Requested: Consider participating in a Medication for Opioid Use Disorder (MOUD) in Primary Care Learning Collaborative. The learning collaborative will address both best clinical practices and developing clinical systems to support an MOUD program in a primary care clinic setting. The opportunity is open to healthcare organizations who want to begin offering MOUD treatment Health Advisory: Opportunity to Participate in a Medication for Opioid Use Disorder (MOUD) Learning Collaborative

Kitsap Respiratory Illness Report November 7 – November 13, 2021

Click here to access the latest Kitsap Respiratory Illness Report: 11.7.21 – 11.13.21.

Kitsap Respiratory Illness Report October 31 – November 6, 2021

Click here to access the latest Kitsap Respiratory Illness Report: 10.31.21 – 11.6.21.

Health Advisory: COVID-19 Updates for Kitsap Healthcare Providers: Vaccine for Children 5-11 years old

Actions Requested: Be aware, on Nov. 2, Centers for Disease Control and Prevention (CDC) recommended the Pfizer-BioNTech vaccine for children 5–11 years old under the Food and Drug Administration’s (FDA’s) emergency use authorization (EUA). Reach out to your pediatric patients and their caregivers and strongly recommend vaccination for all children five and older. Utilize provider Health Advisory: COVID-19 Updates for Kitsap Healthcare Providers: Vaccine for Children 5-11 years old

Kitsap Respiratory Illness Report October 24 – October 30, 2021

Click here to access the latest Kitsap Respiratory Illness Report: 10.24.21 – 10.30.21.

Health Advisory: 2021-2022 Influenza Season For Kitsap Healthcare Providers

Actions Requested: SURVEILLANCE To aid testing and treatment decisions, healthcare providers must stay aware of current local, regional, and national influenza and SARS-CoV-2 activity. Seasonal influenza surveillance begins in September and continues through the month of May. Influenza, RSV, and SARS-CoV-2 will likely circulate simultaneously. Local surveillance data is critical when making testing and treatment decisions. Throughout Health Advisory: 2021-2022 Influenza Season For Kitsap Healthcare Providers

Health Advisory: COVID-19 Updates For Kitsap Healthcare Providers

Actions Requested: Be aware of vaccine booster approvals and recommendations: On October 22, the Centers for Disease Control and Prevention (CDC) recommended a single booster dose of Moderna SARS-CoV-2 vaccine to certain high risk populations at least 6 months after their primary series under the Food and Drug Administration’s (FDA) expanded emergency use authorization (EUA). Health Advisory: COVID-19 Updates For Kitsap Healthcare Providers

Kitsap Respiratory Illness Report October 17 – October 23, 2021

Click here to access the latest Kitsap Respiratory Illness Report: 10.17.21 – 10.23.21.